id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-N-0238-0028,FDA,FDA-2006-N-0238,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approval; Expanded Access to Investigational Drugs for Treatment Use",Notice,NAL-Notice of Approval,2011-03-03T05:00:00Z,2011,3,2011-03-03T05:00:00Z,,2015-06-02T17:59:33Z,2011-04739,0,0,0900006480bfe012